Impact of hydroxychloroquine used as DMARD on SARS-CoV-2 tests and infection evolution in a population of 871 patients with inflammatory rheumatic and musculoskeletal diseases

Detalles Bibliográficos
Autores principales: Trefond, Ludovic, Drumez, Elodie, Andre, Marc, Costedoat-Chalumeau, Nathalie, Seror, Raphaèle, Devaux, Mathilde, Dernis, Emmanuelle, Dieudonné, Yannick, El Mahou, Soumaya, Lanteri, Aurelia, Melki, Isabelle, Queyrel, Viviane, Roumier, Mathilde, Schmidt, Jean, Barnetche, Thomas, Thomas, Thierry, Cacoub, Patrice, Belot, Alexandre, Aumaitre, Olivier, Richez, Christophe, Hachulla, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Société française de rhumatologie. Published by Elsevier Masson SAS. 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8152361/
https://www.ncbi.nlm.nih.gov/pubmed/34051385
http://dx.doi.org/10.1016/j.jbspin.2021.105226

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8152361/
https://www.ncbi.nlm.nih.gov/pubmed/34051385
http://dx.doi.org/10.1016/j.jbspin.2021.105226

Ejemplares similares